Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tenaya Therapeutics Inc

0.4515
-0.0033-0.73%
Post-market: 0.45600.0045+1.00%17:52 EDT
Volume:1.45M
Turnover:675.29K
Market Cap:72.94M
PE:-0.34
High:0.4860
Open:0.4700
Low:0.4500
Close:0.4548
Loading ...

Promising Potential of Tenaya Therapeutics: Buy Rating Justified by Financial Backing and Clinical Progress

TIPRANKS
·
03 Feb

Tenaya Therapeutics receives $8M clinical grant from CIRM

TIPRANKS
·
03 Feb

Tenaya Therapeutics Receives $8 Million Clinical Grant From California Institute for Regenerative Medicine

THOMSON REUTERS
·
03 Feb

Tenaya Therapeutics Receives $8 Million Clinical Grant from California Institute for Regenerative Medicine

GlobeNewswire
·
03 Feb

Tenaya Therapeutics Reprices Underwater Stock Options

TIPRANKS
·
29 Jan

TD Cowen Reaffirms Their Buy Rating on Tenaya Therapeutics (TNYA)

TIPRANKS
·
21 Jan

Tenaya Therapeutics: Promising Pipeline and Upcoming Data Releases Support Buy Rating

TIPRANKS
·
14 Jan

Tenaya Therapeutics Announces 2025 Strategic Priorities and Anticipated Milestones

THOMSON REUTERS
·
13 Jan

Tenaya Therapeutics Announces 2025 Strategic Priorities and Anticipated Milestones

GlobeNewswire
·
13 Jan

Largest borrow rate increases among liquid names

TIPRANKS
·
23 Dec 2024

Tenaya Therapeutics Price Target Maintained With a $18.00/Share by HC Wainwright & Co.

Dow Jones
·
18 Dec 2024

Update: Tenaya Shares Sink After Readout of Heart Disease Therapy Shows Manageable Safety Profile

MT Newswires Live
·
18 Dec 2024

Crude Oil Down Over 1%; US Industrial Production Declines In November

Benzinga
·
18 Dec 2024

Leerink Partners Adjusts Tenaya Therapeutics Price Target to $6 From $8, Maintains Outperform Rating

MT Newswires Live
·
18 Dec 2024

Optimistic Outlook on Tenaya Therapeutics’ TN-201 Gene Therapy for Hypertrophic Cardiomyopathy

TIPRANKS
·
18 Dec 2024

Tenaya Therapeutics Inc : Leerink Partners Cuts Target Price to $6 From $8

THOMSON REUTERS
·
18 Dec 2024

Piper bullish on Tenaya, says initial MyPEAK-1 data de-risks higher dosing

TIPRANKS
·
17 Dec 2024

Positive Buy Recommendation for Tenaya Therapeutics Based on Promising TN-201 Gene Therapy Results

TIPRANKS
·
17 Dec 2024

Promising Early Data from Tenaya Therapeutics’ TN-201 Program Justifies Buy Rating

TIPRANKS
·
17 Dec 2024

Tenaya Says TN-201 Gene Therapy Well Tolerated in Initial Hypertrophic Cardiomyopathy Trial Patients

MT Newswires Live
·
17 Dec 2024